A double-blind, randomised, crossover trial of two botulinum toxin type a in patients with spasticity

Botulinum toxin type A (btxA) is one of the main treatment choices for patients with spasticity. Prosigne® a new released botulinum toxin serotype A may have the same effectiveness as Botox® in focal dystonia. However, there are no randomized clinical trials comparing these formulations in spasticit...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2013-02, Vol.8 (2), p.e56479
Hauptverfasser:	Guarany, Fábio Coelho, Picon, Paulo Dornelles, Guarany, Nicole Ruas, dos Santos, Antonio Cardoso, Chiella, Bianca Paula Mentz, Barone, Carolina Rocha, Fendt, Lúcia Costa Cabral, Schestatsky, Pedro
Format:	Artikel
Sprache:	eng
Schlagworte:	Adults Biology Botulinum toxin Botulinum toxin type A Botulinum Toxins, Type A - administration & dosage Botulinum Toxins, Type A - adverse effects Botulinum Toxins, Type A - therapeutic use Child Child, Preschool Children Clinical trials Cross-Over Studies Double-Blind Method Double-blind studies Drug dosages Dystonia Female Formulations Hospitals Humans Internal medicine Male Medical research Medicine Muscle Spasticity - drug therapy Neurology Patients Pharmacists Randomization Rehabilitation Safety Side effects Spasticity Toxins Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!